CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-10 | PATTI JOSEPH M EVP, Corporate Dev & Strategy | Purchase | +400 | $2.62 | $1K | 56,625 |
| 2014-05-15 | VANLENT ANNE Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-05-15 | Hill Richard James Director | Grant or award | +7,500 | 7,500 | ||
| 2014-05-15 | Fox James Director | Grant or award | +7,500 | $2.85 | $21K | 7,500 |
| 2014-05-15 | Richard John P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-05-15 | DOUGHERTY MICHAEL R Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-05-15 | COX GEOFFREY F Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2013-12-05 | PLUMB RUSSELL H CEO & President | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2013-12-05 | PLUMB RUSSELL H CEO & President | Grant or award · Market Stock Units | +25,000 | 25,000 | ||
| 2013-12-05 | PATTI JOSEPH M EVP, Corporate Dev & Strategy | Grant or award · Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2013-12-05 | PATTI JOSEPH M EVP, Corporate Dev & Strategy | Grant or award · Market Stock Units | +15,625 | 15,625 | ||
| 2013-12-05 | Azzarello Peter Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2013-12-05 | Azzarello Peter Chief Accounting Officer | Grant or award · Market Stock Units | +4,375 | 4,375 | ||
| 2013-08-13 | Richard John P Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2013-05-01 | Hill Richard James Director | Grant or award | +8,700 | 9,950 | ||
| 2013-05-01 | Fox James Director | Grant or award | +8,700 | 8,700 | ||
| 2013-05-01 | Cook Peter Chapman Director | Grant or award | +8,700 | 100,127 | ||
| 2013-05-01 | Hill Richard James Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2013-05-01 | Errington Jeffery Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2013-05-01 | Fox James Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 25 of 42 · 830 trades